Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)

v3.22.2.2
Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Debt Instrument [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 9,975,306 11,710,421 9,975,306 12,620,861
Convertible notes        
Debt Instrument [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 0 19,324 0 19,324
Warrants        
Debt Instrument [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 5,636,801 7,676,112 5,636,801 7,676,112
Options        
Debt Instrument [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 984,729 207,257 984,729 1,117,697
Restricted stock units        
Debt Instrument [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 3,353,776 3,807,154 3,353,776 3,807,154
Restricted shares        
Debt Instrument [Line Items]        
Antidilutive securities excluded from computation of earnings per share (in shares) 0 574 0 574